These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 30995807)
1. Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-Mycobacterial Agents against Mycobacterium avium Complex. Hosoda K; Koyama N; Kanamoto A; Tomoda H Molecules; 2019 Apr; 24(8):. PubMed ID: 30995807 [No Abstract] [Full Text] [Related]
2. Development of an in vivo-mimic silkworm infection model with Mycobacterium avium complex. Yagi A; Yamazaki H; Terahara T; Yang T; Hamamoto H; Imada C; Tomoda H; Uchida R Drug Discov Ther; 2021 Jan; 14(6):287-295. PubMed ID: 33250497 [TBL] [Abstract][Full Text] [Related]
3. Difference in drug susceptibility distribution and clinical characteristics between Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797 [No Abstract] [Full Text] [Related]
4. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens. Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates. Huang CC; Wu MF; Chen HC; Huang WC J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770 [TBL] [Abstract][Full Text] [Related]
7. Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China. Zheng HW; Pang Y; He GX; Song YY; Zhao YL Biomed Environ Sci; 2017 Jul; 30(7):517-525. PubMed ID: 28756811 [TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan. Yamaba Y; Ito Y; Suzuki K; Kikuchi T; Ogawa K; Fujiuchi S; Hasegawa N; Kurashima A; Higuchi T; Uchiya KI; Watanabe A; Niimi A J Infect Chemother; 2019 Dec; 25(12):995-1000. PubMed ID: 31239192 [TBL] [Abstract][Full Text] [Related]
9. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China. Zhao X; Wang Y; Pang Y Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955 [TBL] [Abstract][Full Text] [Related]
11. Nationwide analysis of Mycobacterium chimaera and Mycobacterium intracellulare isolates: Frequency, clinical importance, and molecular and phenotypic resistance profiles. Truden S; Žolnir-Dovč M; Sodja E; Starčič Erjavec M Infect Genet Evol; 2020 Aug; 82():104311. PubMed ID: 32247868 [TBL] [Abstract][Full Text] [Related]
13. Mavintramycin A is a promising antibiotic for treating Hosoda K; Koyama N; Shigeno S; Nishimura T; Hasegawa N; Kanamoto A; Ohshiro T; Tomoda H Antimicrob Agents Chemother; 2024 Mar; 68(3):e0091723. PubMed ID: 38334410 [No Abstract] [Full Text] [Related]
14. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo. Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635 [TBL] [Abstract][Full Text] [Related]
15. Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations. Andréjak C; Almeida DV; Tyagi S; Converse PJ; Ammerman NC; Grosset JH Antimicrob Agents Chemother; 2015 Apr; 59(4):2129-35. PubMed ID: 25624335 [TBL] [Abstract][Full Text] [Related]
16. Steffimycin E, a new anti-mycobacterial agent against Mycobacterium avium complex, produced by Streptomyces sp. OPMA02852. Koyama N; Shigeno S; Kanamoto A; Tomoda H J Antibiot (Tokyo); 2020 Aug; 73(8):581-584. PubMed ID: 32132675 [TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates. Lin S; Hua W; Wang S; Zhang Y; Chen X; Liu H; Shao L; Chen J; Zhang W BMC Microbiol; 2022 Jul; 22(1):175. PubMed ID: 35804298 [TBL] [Abstract][Full Text] [Related]
18. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014. Lee MR; Chien JY; Huang YT; Liao CH; Shu CC; Yu CJ; Hsueh PR Int J Antimicrob Agents; 2017 Jul; 50(1):35-40. PubMed ID: 28478210 [TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs]. Tomioka H; Sato K; Saito H Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791 [TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection. Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]